Anavex Life Sciences Corp. Appoints VP Business Development and VP Strategic Planning

Geneva, Switzerland — February 07, 2007 — Anavex Life Sciences Corp. (OTCBB: AVXL) (the “Company”) announces that Ms. Angela Vernadaki and Dr. George Kalkanis have been appointed as Officers of the Company. Ms. Vernadaki, appointed as VP Business Development, brings more than ten years of experience in marketing, sales, business development and entrepreneurship in the…